132 related articles for article (PubMed ID: 2724547)
1. [Prognostic factors in gastric cancer with serosal invasion--importance of the extent of cancer infiltration in the subserosal layer].
Habu H; Kando F; Saito N; Takeshita K; Sunagawa M; Endo M
Gan No Rinsho; 1989 May; 35(6):685-9. PubMed ID: 2724547
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of the width of subserosal invasion in gastric cancer invading the subserosal layer.
Soga K; Ichikawa D; Yasukawa S; Kubota T; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Sakakura C; Kokuba Y; Yanagisawa A; Otsuji E
Surgery; 2010 Feb; 147(2):197-203. PubMed ID: 19758672
[TBL] [Abstract][Full Text] [Related]
3. Magnitude of serosal changes predicts peritoneal recurrence of gastric cancer.
Bando E; Kawamura T; Kinoshita K; Takahashi S; Maeda A; Osada S; Tsubosa Y; Yamaguchi S; Uesaka K; Yonemura Y
J Am Coll Surg; 2003 Aug; 197(2):212-22. PubMed ID: 12892799
[TBL] [Abstract][Full Text] [Related]
4. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration.
Isozaki H; Tanaka N; Fujii K; Tanigawa N; Okajima K
Hepatogastroenterology; 2001; 48(40):1179-82. PubMed ID: 11490828
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
[TBL] [Abstract][Full Text] [Related]
7. Is bursectomy necessary for patients with gastric cancer invading the serosa?
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Hasegawa S; Ishiwa N; Morinaga S; Noguchi Y; Yamamoto Y; Matsumoto A
Hepatogastroenterology; 2004; 51(59):1524-6. PubMed ID: 15362792
[TBL] [Abstract][Full Text] [Related]
8. [Relation of the serosal invasion mode to a recurrence in advanced gastric carcinomas].
Matsusaka T; Wakasugi K; Takenaka M; Kume K; Fujinaga Y; Iwashita A
Gan No Rinsho; 1989 Jul; 35(8):917-22. PubMed ID: 2545938
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing outcome in gastric cancer involving muscularis and subserosal layer.
Fotia G; Marrelli D; De Stefano A; Pinto E; Roviello F
Eur J Surg Oncol; 2004 Nov; 30(9):930-4. PubMed ID: 15498636
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal recurrence of gastric adenocarcinoma after curative resection.
Lee CC; Lo SS; Wu CW; Shen KH; Li AF; Hsieh MC; Lui WY
Hepatogastroenterology; 2003; 50(53):1720-2. PubMed ID: 14571826
[TBL] [Abstract][Full Text] [Related]
12. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.
Ikeguchi M; Oka A; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 1994; 14(5B):2131-4. PubMed ID: 7840512
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer.
Tsujitani S; Kakeji Y; Watanabe A; Kohnoe S; Maehara Y; Sugimaghi K
Int Surg; 1992; 77(4):238-41. PubMed ID: 1478802
[TBL] [Abstract][Full Text] [Related]
14. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion: a prospective, multicenter study.
Fujiwara Y; Okada K; Hanada H; Tamura S; Kimura Y; Fujita J; Imamura H; Kishi K; Yano M; Miki H; Okada K; Takayama O; Aoki T; Mori M; Doki Y
Surgery; 2014 Mar; 155(3):417-23. PubMed ID: 24439740
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study.
Yonemura Y; de Aretxabala X; Fujimura T; Fushida S; Katayama K; Bandou E; Sugiyama K; Kawamura T; Kinoshita K; Endou Y; Sasaki T
Hepatogastroenterology; 2001; 48(42):1776-82. PubMed ID: 11813623
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.
Kaibara N; Hamazoe R; Iitsuka Y; Maeta M; Koga S
Hepatogastroenterology; 1989 Apr; 36(2):75-8. PubMed ID: 2499527
[TBL] [Abstract][Full Text] [Related]
17. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in gastric cancer].
Nishi M; Nakajima T
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2186-93. PubMed ID: 3408252
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
20. Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.
Yamashita K; Sakuramoto S; Katada N; Futawatari N; Moriya H; Hirai K; Kikuchi S; Watanabe M
Hepatogastroenterology; 2009; 56(89):276-81. PubMed ID: 19453074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
